Crossref Citations
This article has been cited by the following publications. This list is generated based on data provided by Crossref.
Häberle, Johannes
2013.
Clinical and biochemical aspects of primary and secondary hyperammonemic disorders.
Archives of Biochemistry and Biophysics,
Vol. 536,
Issue. 2,
p.
101.
Tan, Y.
Li, W.
Chen, Y.
Deng, Y.
and
Xiao, J.
2014.
Bi-weekly docetaxel and 5-fluorouracil: an effective and feasible treatment for advanced gastric cancer with poor performance status.
Gastroenterology Report,
Vol. 2,
Issue. 4,
p.
295.
Kumar, Sumit
and
Asrani, Sumeet K.
2015.
Non-cirrhotic Hyperammonemia—When High Ammonia Is not Always from Cirrhosis.
Current Hepatology Reports,
Vol. 14,
Issue. 1,
p.
25.
Mitani, Seiichiro
Kadowaki, Shigenori
Komori, Azusa
Sugiyama, Keiji
Narita, Yukiya
Taniguchi, Hiroya
Ura, Takashi
Ando, Masashi
Sato, Yozo
Yamaura, Hidekazu
Inaba, Yoshitaka
Ishihara, Makoto
Tanaka, Tsutomu
Tajika, Masahiro
and
Muro, Kei
2017.
Acute hyperammonemic encephalopathy after fluoropyrimidine-based chemotherapy.
Medicine,
Vol. 96,
Issue. 22,
p.
e6874.
Caldovic, Ljubica
2019.
Gene Expression and Control.
Heibel, Sandra K.
McGuire, Peter J.
Haskins, Nantaporn
Majumdar, Himani D.
Rayavarapu, Sree
Nagaraju, Kanneboyina
Hathout, Yetrib
Brown, Kristy
Tuchman, Mendel
and
Caldovic, Ljubica
2019.
AMP‐activated protein kinase signaling regulated expression of urea cycle enzymes in response to changes in dietary protein intake.
Journal of Inherited Metabolic Disease,
Vol. 42,
Issue. 6,
p.
1088.
Diaz, Maria
and
Schiff, David
2020.
Central Nervous System Metastases.
p.
329.